Investors of MacroGenics, Inc. Encouraged to Act
Investors in MacroGenics, Inc. (NASDAQ: MGNX) are urged to reach out to Levi & Korsinsky, LLP to learn about their important legal rights and opportunities. A significant class action lawsuit is currently underway, raising concerns in the investment community due to allegations of securities fraud that have affected many shareholders.
Insights into the Class Action Lawsuit
This lawsuit centers on the losses incurred by investors in MacroGenics during a specific timeframe when serious misrepresentations regarding the company’s drug safety data came to light. A pivotal moment occurred when it was disclosed that the safety profile for vobramitamab duocarmazine was much more alarming than what the company had initially communicated.
Who Is Impacted?
Investors who purchased shares of MacroGenics within the specified dates should pay close attention. If you invested during this time and faced losses, you may qualify to participate in this class action.
The Allegations Explained
The class action is based on claims that the defendants failed to be transparent about the drug's risks during the relevant period. A startling announcement on May 9 resulted in a dramatic 77.4% drop in the company's stock price, translating to a loss of $11.36 per share. This event sent shockwaves through the trading community, highlighting the urgency for shareholders to take notice.
Next Steps for Investors
As the deadline approaches, affected investors have a clear course of action. You have until September 24, 2024 to make your voice heard in the court proceedings, making it crucial to claim your share of any potential recovery.
No Costs for Participation
It’s important to note that joining this class action comes with no direct costs for investors. In fact, participants may be able to recover funds without incurring any out-of-pocket expenses, making it accessible for all affected individuals.
Why Choose Levi & Korsinsky?
Levi & Korsinsky has a strong history of advocating for investors over the past twenty years, successfully securing hundreds of millions for their clients. Known for their expertise in high-stakes securities litigation, the firm has earned a national reputation for their dedication to protecting investor rights.
How to Get Assistance
If you're interested in taking action or want to learn more about your rights as an investor in MacroGenics, reach out to Joseph E. Levi, Esq. You can email him directly or contact the firm by phone. They are ready to provide you with information tailored to your specific situation.
Contact Information
You can reach Joseph E. Levi at [email protected] or call (212) 363-7500.
Office Address for Levi & Korsinsky, LLP
If you prefer to connect with them in person or via traditional mail, their office address is: 33 Whitehall Street, 17th Floor, New York, NY 10004.
Frequently Asked Questions
What should I do if I invested in MacroGenics during the critical period?
If you bought shares during the relevant dates of the alleged fraud, reaching out to Levi & Korsinsky is a wise first step to understand your rights.
How much will it cost me to participate in this class action?
Participation in the class action incurs no costs or fees for class members, allowing you to pursue your claim without any financial concerns.
What risk is involved in joining the class action lawsuit?
The main risk lies in not joining and potentially missing the opportunity for financial recovery if your investment was negatively affected during the alleged timeframe.
Will I need to appear in court?
While you may not need to appear in court, it’s advisable to remain informed and available in case representatives need to contact you for updates.
How can I stay updated on this lawsuit?
The best way to stay informed is to maintain close communication with your legal team at Levi & Korsinsky, who will provide updates on significant developments in the case.
